Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 81 references it cites were found in a registry or an index.
Abstract
To examine the prevalence and incidence of diabetic eye disease (DED) among individuals with diabetes in Europe, a systematic review to identify all published European prevalence and incidence studies of DED in individuals with diabetes managed in primary health care was performed according to the MOOSE and PRISMA guidelines. The databases Medline, Embase and Web of Science were searched to 2 September 2017. Meta-analyses and meta-regressions were performed. The pooled prevalence estimates were applied to diabetes prevalence rates provided by the International Diabetes Foundation atlas and Eurostat population data, and extrapolated to the year 2050. Data of 35 prevalence and four incidence studies were meta-analyzed. Any diabetic retinopathy (DR) and diabetic macular edema (DME) were prevalent in 25.7% (95% CI 22.8-28.8%) and 3.7% (95% CI 2.2-6.2%), respectively. In meta-regression, the prevalence of DR in persons with type 1 diabetes was significantly higher compared to persons with type 2 diabetes (54.4% vs. 25.0%). The pooled mean annual incidence of any DR and DME in in persons with type 2 diabetes was 4.6% (95% CI 2.3-8.8%) and 0.4% (95% CI 0.5-1.4%), respectively. We estimated that persons with diabetes affected by any DED in Europe will increase from 6.4 million today to 8.6 million in 2050, of whom 30% require close monitoring and/or treatment. DED is estimated to be present in more than a quarter of persons with type 2 diabetes and half of persons with type 1 diabete…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prognosis for retaining vision has improved dramatically over the past 40 years owing to improved metabolic and BP control.78,432,488–490”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [489]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 4×
“The Meta-analysis for Eye Disease (META-EYE) study group has provided pooled global data on the prevalence and major risk factors of DR [3] and reported a prevalence of 34.”
BackgroundInfluentialWilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Research works printed but not linked: 7
- Schwarzer G. Meta: an R package for meta-analysis. R News. 2007;7:40–5.
- Gil Hernández MA, Abreu Reyes P, Pareja Rios A, Martinez Piñero A. Estudio de la retinopatía diabética en la población de la isla de Hierro. Arch Soc Canar Oftal. 2000;11:23–6.
- Bueso E, Fernandez-Vigo J, Perez C, Merino A, Perianes J. Prevalence of diabetic retinopathy in the Regional Community of Extremadura. 1997–2001 (Extremadura Project to Prevent Blindness). Arch Soc Esp Oftalmol. 2005;80:187–94.
- Santos-Bueso E, Fernandez-Perez C, Macarro A, Fernandez-Vigo J. Prevalence of diabetic retinopathy in the city of Badajoz 2002 (Extremadura project to prevent blindness). Arch Soc Esp Oftalmol. 2007;82:153–8.
- Teruel MC, Fernandez-Real JM, Ricart W, Valent FR, Valles PM. Prevalence of diabetic retinopathy in the region of Girona. Study of related factors. Arch Soc Esp Oftalmol. 2005;80:85–91.
- Diabetic Retinopathy Study Research Group. Report No. 7: a modification of the Airlie House classification of diabetic retinopathy. Investig Ophthalmol Vis Sci. 1981;21:210–26.
- Facey K, Cummins E, Macpherson K, Morris A, Reay L, Slattery J. Health technology assessment report 1: organisations of services for diabetic retinopathy screening. Glasgow: Health Technology Board for Scotland; 2002.
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Im, J. H. B., Jin, Y.-P., Chow, R., & Yan, P. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.01.009 · Cited by 136
Recent Advances in Age-Related Macular Degeneration Therapies
Fabre, M., Mateo, L., Lamaa, D., Baillif, S., Pagès, G., Demange, L., Ronco, C., & Benhida, R. (2022) · Molecules · doi:10.3390/molecules27165089 · Cited by 110
Liu, R., Li, L., Shao, C., Cai, H., & Wang, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1531289 · Cited by 98
“…on future predictions show that the incidence of diabetes in Europe is expected to increase by 2 million people over the next 30 years; approximately 50% of patients with type 1 diabetes and approximately 25% of patients with type 2 diabetes will continue to su ff er from diabetic eye disease [81].”
Background
Metadata
- Authors
- Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P.
- Affiliations
- University of Bonn (DE)
- Hospital Universitari i Politècnic La Fe (ES)
- Corresponding author
- Finger, Robert P.
- ORCID
- Venue
- European Journal of Epidemiology
- Published
- 2019-09-12
- Volume
- 35
- Issue
- 1
- Pages
- 11-23
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- OpenAlex
- W2972391601
- Cited by
- 179
- References
- 81
- Citations by year
- 2026: 18 · 2025: 23 · 2024: 29 · 2023: 31 · 2022: 39 · 2021: 28 · 2020: 11
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Society of Retina Specialists
- Jackstaedt Stiftung
- Else Kröner-Fresenius-Stiftung
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic eye disease, diabetic retinopathy, diabetic macular edema, prevalence, incidence, type 1 diabetes, type 2 diabetes, future projections, primary care, health planning, Europe
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Europe, Female, Humans, Macular Edema, Male, Risk Factors, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s10654-019-00560-z
- The paper
- Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P. (2020). Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis. European Journal of Epidemiology. https://doi.org/10.1007/s10654-019-00560-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.